DE60021098D1 - Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung - Google Patents
Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellungInfo
- Publication number
- DE60021098D1 DE60021098D1 DE60021098T DE60021098T DE60021098D1 DE 60021098 D1 DE60021098 D1 DE 60021098D1 DE 60021098 T DE60021098 T DE 60021098T DE 60021098 T DE60021098 T DE 60021098T DE 60021098 D1 DE60021098 D1 DE 60021098D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- resin
- isoagglutinine
- regeneration
- free blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
- 239000008280 blood Substances 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000011069 regeneration method Methods 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 230000008929 regeneration Effects 0.000 abstract 2
- 102000029797 Prion Human genes 0.000 abstract 1
- 108091000054 Prion Proteins 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 244000052613 viral pathogen Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
- B01D15/203—Equilibration or regeneration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41585499A | 1999-10-08 | 1999-10-08 | |
PCT/US2000/027711 WO2001027623A2 (en) | 1999-10-08 | 2000-10-06 | Isoagglutinin-depleted blood compositions and methods of making same |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60021098D1 true DE60021098D1 (de) | 2005-08-04 |
DE60021098T2 DE60021098T2 (de) | 2006-06-14 |
Family
ID=23647483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60021098T Revoked DE60021098T2 (de) | 1999-10-08 | 2000-10-06 | Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1224462B1 (de) |
JP (1) | JP2003511468A (de) |
AT (1) | ATE298889T1 (de) |
AU (1) | AU1074601A (de) |
CA (1) | CA2385179A1 (de) |
DE (1) | DE60021098T2 (de) |
ES (1) | ES2240187T3 (de) |
MX (1) | MXPA02003517A (de) |
WO (1) | WO2001027623A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7001873B2 (en) * | 2001-10-05 | 2006-02-21 | Steris Inc. | Decontamination of surfaces contaminated with prion-infected material with oxidizing agent-based formulations |
US7803315B2 (en) * | 2001-10-05 | 2010-09-28 | American Sterilizer Company | Decontamination of surfaces contaminated with prion-infected material with gaseous oxidizing agents |
MX287895B (es) * | 2003-04-08 | 2011-06-30 | Novo Nordisk As | Regeneracion de fases estacionarias cromatograficas. |
BRPI0408978B8 (pt) | 2003-04-08 | 2021-07-27 | Novo Nordisk As | processos para regenerar uma fase estacionária cromatográfica |
EP1506809A1 (de) * | 2003-08-11 | 2005-02-16 | Boehringer Ingelheim Pharma GmbH & Co. KG | Regenerierung von hydrolyseempfindlichen Adsorptionsmatrizen |
EP1506810A1 (de) * | 2003-08-11 | 2005-02-16 | Boehringer Ingelheim Pharma GmbH & Co.KG | Regenerierung von hydrolyseempfindlichen Adsorptionsmatrizen |
DE102004009400A1 (de) | 2004-02-24 | 2005-09-08 | Zlb Behring Gmbh | Fibrinogen Reinigung |
WO2006126942A1 (en) * | 2005-05-24 | 2006-11-30 | Ge Healthcare Bio-Sciences Ab | Regeneration of a chromatography matrix |
FR2895263B1 (fr) | 2005-12-26 | 2008-05-30 | Lab Francais Du Fractionnement | Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives |
US9102709B1 (en) * | 2011-07-08 | 2015-08-11 | Biogen Ma Inc. | Regeneration of chromatography material |
WO2014049063A1 (en) * | 2012-09-26 | 2014-04-03 | Bone Therapeutics S.A. | Formulations involving solvent/detergent-treated plasma (s/d plasma) and uses thereof |
FR3026950A1 (fr) * | 2014-10-09 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de plasma universel |
GB201503578D0 (en) * | 2015-03-03 | 2015-04-15 | Ge Healthcare Bio Sciences Ab | Sanitization method for affinity chromatography matrices |
FR3035789A1 (fr) * | 2015-05-07 | 2016-11-11 | Lab Francais Du Fractionnement | Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b pour son utilisation dans le traitement des maladies autoimmunes ou des polyglobulies |
FR3035971A1 (fr) | 2015-05-07 | 2016-11-11 | Lab Francais Du Fractionnement | Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b |
US20170066839A1 (en) * | 2015-09-08 | 2017-03-09 | Merck Patent Gmbh | Novel affinity chromatography media for removal of anti-a and/or anti-b antibodies |
US10697982B2 (en) | 2015-09-08 | 2020-06-30 | Merck Patent Gmbh | Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies |
US10697983B2 (en) * | 2015-09-08 | 2020-06-30 | Merck Patent Gmbh | Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies |
EP3254671B1 (de) | 2016-06-10 | 2019-11-13 | Octapharma AG | Hochkonzentrierte immunglobulinzusammensetzung zur pharmazeutischen anwendung |
KR101941974B1 (ko) * | 2016-11-18 | 2019-01-24 | 주식회사 녹십자 | 혈장 단백질 정제시 fxi의 제거방법 |
IL312404A (en) * | 2017-01-30 | 2024-06-01 | Regeneron Pharma | Preparations and methods for reducing biological load in chromatography |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4664913A (en) * | 1982-05-24 | 1987-05-12 | Xoma Corporation | Method for treating plasma for transfusion |
AU667530B2 (en) * | 1992-05-28 | 1996-03-28 | New York Blood Center, Inc., The | Removal of antibodies from blood-derived compositions while retaining coagulation factors |
-
2000
- 2000-10-06 MX MXPA02003517A patent/MXPA02003517A/es unknown
- 2000-10-06 JP JP2001530582A patent/JP2003511468A/ja active Pending
- 2000-10-06 AT AT00972027T patent/ATE298889T1/de not_active IP Right Cessation
- 2000-10-06 EP EP00972027A patent/EP1224462B1/de not_active Revoked
- 2000-10-06 CA CA002385179A patent/CA2385179A1/en not_active Abandoned
- 2000-10-06 WO PCT/US2000/027711 patent/WO2001027623A2/en active IP Right Grant
- 2000-10-06 ES ES00972027T patent/ES2240187T3/es not_active Expired - Lifetime
- 2000-10-06 AU AU10746/01A patent/AU1074601A/en not_active Abandoned
- 2000-10-06 DE DE60021098T patent/DE60021098T2/de not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
MXPA02003517A (es) | 2004-09-10 |
AU1074601A (en) | 2001-04-23 |
CA2385179A1 (en) | 2001-04-19 |
WO2001027623A3 (en) | 2002-01-17 |
ES2240187T3 (es) | 2005-10-16 |
JP2003511468A (ja) | 2003-03-25 |
WO2001027623A2 (en) | 2001-04-19 |
ATE298889T1 (de) | 2005-07-15 |
EP1224462B1 (de) | 2005-06-29 |
DE60021098T2 (de) | 2006-06-14 |
EP1224462A2 (de) | 2002-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60021098T2 (de) | Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung | |
ATE402753T1 (de) | Reinigung von ionischen flüssigkeiten | |
DE10394131D2 (de) | Verfahren zur Trennung von Gasgemischen und Gaszentrifuge zur Durchführung des Verfahrens | |
DE69929986D1 (de) | Verfahren zur entfernung von hiv und anderen viren aus blut | |
DE69737294D1 (de) | Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält | |
ATE278785T1 (de) | Neues verfahren zur gewinnung und reinigung von fusionsproteinen | |
ATE517180T1 (de) | Verwendung von esterasen zur spaltung von kunststoffen | |
DE69913320D1 (de) | Verfahren zur behandlung von gas-strömen bei der polyolefinherstellung | |
ATE449104T1 (de) | Verfahren zur reinigung von fibrinogen | |
DE60221838D1 (de) | Verfahren zur herstellung von aufgeschäumten polypropylenharzteilchen | |
DE60239100D1 (de) | Verfahren zur trennung von polyester von anderen materialien | |
DE69801548T2 (de) | Verfahren zur Reinigung von 1,4-Butandiol durch Schmelzkristallisation | |
DE69820580D1 (de) | Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen | |
DE60237649D1 (de) | Flüssigkeitsfiltrierverfahren | |
FR2861395B1 (fr) | Facteur viii viralement securise a faible teneur en multimeres superieurs | |
DE50311487D1 (de) | Verfahren zur Herstellung von Kompositmembranen | |
DK1101735T3 (da) | Fremgangsmåde til fjernelse af skabelonmidlet fra syntetiske zeolitter | |
DE50006245D1 (de) | Verfahren zur herstellung von (1,1':4',1'')-terphenylvebindungen | |
BRPI0408899A (pt) | compostos benzo[1,2,5]tiadiazol | |
ATE294250T1 (de) | Vorrichtung zur filtration von und zugabe von kornfeinungsmittel zu metallschmelzen | |
DE69924390D1 (de) | Kohlenstoffaserfilter | |
Burnouf | Current status and new developments in the production of plasma derivatives | |
DE59912502D1 (de) | Verfahren zur herstellung von enantiomerenreinem n-methyl- n- (1s)- 1-phenyl- 2-((3s)-3- hydroxypyrrolidin- 1-yl)ethyl]- 2,2- diphenylacetamid | |
DE60226931D1 (de) | Verfahren zur Herstellung von Polyester, Verfahren zur Herstellung von substituierter alpha-Hydroxycarbonsäure und Clostridium beijerinckii-Stamm HICA432 | |
DE60333077D1 (de) | Neues verfahren zur herstellung von 1,2-diol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de | ||
8370 | Indication related to discontinuation of the patent is to be deleted | ||
8363 | Opposition against the patent | ||
8331 | Complete revocation |